Related references
Note: Only part of the references are listed.Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study
J. M. Fernandez-Armenteros et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Cholesterol-Lowering Agents Statins-For Everyone?
Savvas Hadjiphilippou et al.
CIRCULATION RESEARCH (2019)
Obesity and dyslipidemia in patients with psoriasis A case-control study
Chaoyang Miao et al.
MEDICINE (2019)
Childhood and Adolescent Psoriasis in Taiwan: A Retrospective Analysis from a Single Medical Center
Hsi Yen et al.
DERMATOLOGICA SINICA (2019)
Do statins induce or protect from acute kidney injury and chronic kidney disease: An update review in 2018
An Verdoodt et al.
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2018)
Psoriasis and comorbid diseases Epidemiology
Junko Takeshita et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis
William C. Ports et al.
CLINICAL DRUG INVESTIGATION (2017)
Kidney disease and psoriasis: novel evidences beyond old concepts
Luca Visconti et al.
CLINICAL RHEUMATOLOGY (2016)
Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
Xiaole Su et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009
Kim Alexander Papp et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2016)
Pleiotropic effects of statins: new therapeutic targets in drug design
Onkar Bedi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis
Zhenhong Zhang et al.
PHARMACOLOGICAL RESEARCH (2016)
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
Hsin-Hui Yu et al.
ATHEROSCLEROSIS (2015)
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study
H-Y Chiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Statins in chronic kidney disease: what do meta-analyses tell us?
Ashish Upadhyay
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone
Lihi Eder et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The association between psoriasis and dyslipidaemia: a systematic review
C. Ma et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study
Joy Wan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study
Ming-Nan Lai et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
HDL metabolism and activity in chronic kidney disease
Nosratola D. Vaziri et al.
NATURE REVIEWS NEPHROLOGY (2010)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Share Paper
